Platform Leadership

Raymond Lam, MD, FRCPC
Roumen Milev, MD, PhD, FRCPC

Active Sites

The Clinical Outcomes Platform operates at the following research sites:

  • Centre for Addiction and Mental Health (Toronto, Ontario)
  • Dalhousie University (Halifax, Nova Scotia)
  • Queen’s University (Kingston, Ontario)
  • St. Joseph’s Healthcare Hamilton (Hamilton, Ontario)
  • St. Michael’s Hospital (Toronto, Ontario)
  • University of British Columbia (Vancouver, British Columbia)
  • University of Calgary (Calgary, Alberta)
  • University Health Network (Toronto, Ontario)

Platform Overview

The Clinical Platform is responsible for developing study protocols and ensuring the highest safety standards for study participants. This includes determining the most appropriate study population, study design and clinical assessments for each study. The Clinical team ensures clinical studies are carried out in accordance with the developed study protocols, Good Clinical Practice (GCP) as defined by the International Conference on Harmonization (ICH), the principles of the Declaration of Helsinki, and with local regulations. The Clinical Platform uses a comprehensive range of clinical interviews and self-reports to collect clinical outcome measures. These tools assess dimensions of mood, anxiety, circadian rhythms, personality, life experiences, cognition, functional outcomes, and other dimensions as required by each study.